Aethlon Medical Financials
AEMD Stock | USD 0.37 0.02 5.71% |
Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
---|---|---|---|---|---|---|---|---|---|
Current Ratio | 2.15 | 3.2504 |
|
|
Investors should never underestimate Aethlon Medical's ability to pay suppliers on time, ensure interest payments are not accumulating, and correctly time where and how to reinvest extra cash. Individual investors need to monitor Aethlon Medical's cash flow, debt, and profitability to make informed and accurate decisions about investing in Aethlon Medical.
Net Income |
|
Aethlon | Select Account or Indicator |
Understanding current and past Aethlon Medical Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Aethlon Medical's financial statements are interrelated, with each one affecting the others. For example, an increase in Aethlon Medical's assets may result in an increase in income on the income statement.
Please note, the presentation of Aethlon Medical's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Aethlon Medical's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Aethlon Medical's management manipulating its earnings.
Aethlon Medical Stock Summary
Aethlon Medical competes with Tivic Health, Bluejay Diagnostics, Heart Test, Nuwellis, and Bone Biologics. Aethlon Medical, Inc., a medical technology company, focuses on developing products to diagnose and treat life and organ threatening diseases in the United States. The company was founded in 1999 and is based in San Diego, California. Aethlon Medical operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 14 people.Specialization | Health Care, Health Care Equipment & Services |
Instrument | USA Stock View All |
Exchange | NASDAQ Exchange |
ISIN | US00808Y3071 |
CUSIP | 00808Y307 00808Y208 00808Y406 00808Y109 |
Location | California; U.S.A |
Business Address | 11555 Sorrento Valley |
Sector | Health Care Equipment & Supplies |
Industry | Health Care |
Benchmark | Dow Jones Industrial |
Website | www.aethlonmedical.com |
Phone | 619 941 0360 |
Currency | USD - US Dollar |
Aethlon Medical Key Financial Ratios
Return On Equity | -1.05 | ||||
Price To Sales | 2.37 X | ||||
Gross Profit | 574.25 K | ||||
EBITDA | (11.85 M) | ||||
Net Income | (12.21 M) |
Aethlon Medical Key Balance Sheet Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 10.4M | 10.7M | 19.4M | 17.5M | 8.2M | 8.7M | |
Other Current Liab | 584.1K | 880.2K | 852.6K | 802.8K | 761.5K | 723.4K | |
Net Debt | (9.5M) | (9.8M) | (16.3M) | (13.3M) | (4.5M) | (4.3M) | |
Retained Earnings | (112.0M) | (119.9M) | (130.3M) | (142.4M) | (154.6M) | (146.8M) | |
Cash | 9.6M | 9.9M | 17.1M | 14.5M | 5.4M | 3.0M | |
Total Liab | 1.1M | 1.4M | 2.4M | 2.4M | 2.5M | 4.1M | |
Total Current Assets | 10.0M | 10.4M | 18.2M | 15.1M | 5.9M | 3.2M | |
Common Stock | 9.4K | 12.2K | 15.4K | 23.0K | 2.6K | 2.5K | |
Accounts Payable | 285.0K | 337.7K | 500.0K | 432.9K | 777.9K | 566.0K | |
Intangible Assets | 57.5K | 57.0K | 2.2K | 1.7K | 1.1K | 1.0K | |
Other Current Assets | 229.6M | 341.1K | 1.9M | 557.6K | 506.0K | 480.7K | |
Short Term Debt | 98.6K | 42.5K | 126.9K | 269.4K | 290.6K | 276.0K | |
Net Tangible Assets | 9.4M | 9.4M | 17.1M | 15.1M | 17.3M | 18.2M | |
Capital Surpluse | 105.6M | 108.1M | 121.4M | 129.3M | 148.7M | 97.7M |
Aethlon Medical Key Income Statement Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Interest Expense | 54.2K | 1.6K | 123.7K | 131.1M | 150.8M | 158.4M | |
Operating Income | (5.9M) | (7.9M) | (10.4M) | (11.9M) | (12.6M) | (12.0M) | |
Ebit | (5.9M) | (7.9M) | (10.4M) | (11.9M) | (12.2M) | (11.6M) | |
Ebitda | (5.9M) | (7.8M) | (10.3M) | (11.7M) | (11.8M) | (11.3M) | |
Net Income | (6.4M) | (7.8M) | (10.4M) | (12.0M) | (12.2M) | (11.6M) | |
Income Tax Expense | 48.1K | (43.1K) | (4.8K) | 131.1M | 3.0 | 2.85 | |
Gross Profit | 650.2K | 659.1K | 294.2K | 308.9K | (359.1K) | (377.0K) | |
Cost Of Revenue | 2.3B | 3.5B | 4.6B | 265.3K | 359.1K | 341.1K | |
Income Before Tax | (6.4M) | (7.9M) | (10.4M) | (12.0M) | (12.2M) | (12.8M) | |
Research Development | 927K | 2.1M | 2.3M | 2.7M | 2.5M | 2.6M | |
Total Revenue | 229.6K | 650.2K | 659.1K | 294.2K | 574.2K | 0.0 | |
Minority Interest | (6.1K) | (136.9K) | 4.8K | 620.0 | 713.0 | 748.65 | |
Interest Income | 220.5K | 54.2K | 0.0 | 11.0K | 428.4K | 243.0K | |
Net Interest Income | (54.2K) | (1.6K) | 0.0 | 11.0K | 428.4K | 449.8K |
Aethlon Medical Key Cash Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Change In Cash | 5.8M | 303.5K | 7.3M | (2.5M) | (9.1M) | (8.6M) | |
Free Cash Flow | (5.3M) | (6.8M) | (10.1M) | (11.4M) | (10.4M) | (9.9M) | |
Other Non Cash Items | 31.3K | (2.5K) | 30.5K | (46.6M) | 21.3K | 22.3K | |
Net Income | (6.4M) | (7.9M) | (10.4M) | (12.0M) | (12.2M) | (11.6M) | |
End Period Cash Flow | 9.6M | 9.9M | 17.2M | 14.6M | 5.5M | 3.0M | |
Depreciation | 26.4K | 39.9K | 123.7K | 240.9K | 359.1K | 377.0K | |
Change To Inventory | (74.8K) | 8.5K | (104.7K) | 456.6K | 411.0K | 431.5K | |
Change Receivables | (74.8K) | 74.8K | (206.7K) | 57.6K | 66.3K | 69.6K | |
Change To Netincome | 1.2M | 772.1K | 776.4K | 1.2M | 1.1M | 1.6M | |
Investments | (151.7K) | (59.9K) | (349.2K) | (943.1K) | (250.9K) | (263.4K) |
Aethlon Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Aethlon Medical's current stock value. Our valuation model uses many indicators to compare Aethlon Medical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Aethlon Medical competition to find correlations between indicators driving Aethlon Medical's intrinsic value. More Info.Aethlon Medical is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . At present, Aethlon Medical's Return On Equity is projected to increase slightly based on the last few years of reporting. Comparative valuation analysis is a catch-all technique that is used if you cannot value Aethlon Medical by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Aethlon Medical Systematic Risk
Aethlon Medical's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Aethlon Medical volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was one with a total number of output elements of sixty. The Beta measures systematic risk based on how returns on Aethlon Medical correlated with the market. If Beta is less than 0 Aethlon Medical generally moves in the opposite direction as compared to the market. If Aethlon Medical Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Aethlon Medical is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Aethlon Medical is generally in the same direction as the market. If Beta > 1 Aethlon Medical moves generally in the same direction as, but more than the movement of the benchmark.
Today, most investors in Aethlon Medical Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Aethlon Medical's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Aethlon Medical growth as a starting point in their analysis.
Price Earnings To Growth Ratio |
|
Aethlon Medical December 18, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Aethlon Medical help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Aethlon Medical. We use our internally-developed statistical techniques to arrive at the intrinsic value of Aethlon Medical based on widely used predictive technical indicators. In general, we focus on analyzing Aethlon Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Aethlon Medical's daily price indicators and compare them against related drivers.
Downside Deviation | 4.33 | |||
Information Ratio | (0.02) | |||
Maximum Drawdown | 25.97 | |||
Value At Risk | (6.98) | |||
Potential Upside | 7.5 |
Complementary Tools for Aethlon Stock analysis
When running Aethlon Medical's price analysis, check to measure Aethlon Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aethlon Medical is operating at the current time. Most of Aethlon Medical's value examination focuses on studying past and present price action to predict the probability of Aethlon Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aethlon Medical's price. Additionally, you may evaluate how the addition of Aethlon Medical to your portfolios can decrease your overall portfolio volatility.
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments |